MORGAN STANLEY - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 23 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$405,820
+5.8%
788,0000.0%0.00%
Q2 2023$383,677
+22.9%
788,0000.0%0.00%
Q1 2023$312,127
-76.3%
788,000
-69.6%
0.00%
Q4 2022$1,319,362
-0.6%
2,588,0000.0%0.00%
Q3 2022$1,327,000
-5.1%
2,588,0000.0%0.00%
Q2 2022$1,398,000
-32.0%
2,588,000
-36.0%
0.00%
Q1 2022$2,055,000
-43.3%
4,046,000
-42.6%
0.00%
Q4 2021$3,626,0007,046,0000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2022
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders